Chemosensors (Dec 2017)

Challenges in Developing a Biochip for Intact Histamine Using Commercial Antibodies

  • Leena Mattsson,
  • Sara Doppler,
  • Claudia Preininger

DOI
https://doi.org/10.3390/chemosensors5040033
Journal volume & issue
Vol. 5, no. 4
p. 33

Abstract

Read online

This study describes the development and the challenges in the development of an on-chip immunoassay for histamine using commercially available antibodies. Histamine can be used as an indicator of food freshness and quality, but it is also a relevant marker in clinical diagnostics. Due to its low molecular weight, simple structure and thus low immunogenicity production of high specificity and affinity antibodies is difficult. From six commercial anti-histamine antibodies tested, only two bound the histamine free in the solution. A fluorescent on-chip immunoassay for histamine was established with a dynamic range of 8–111 µg/mL using polyclonal anti-histamine antibody H7403 from Sigma (Mendota Heights, MN, USA). The anti-histamine antibodies described and used in published literature are thoroughly reviewed and the quality of commercial antibodies and their traceability and quality issues are highlighted and extensively discussed.

Keywords